Executive Physical — Longevity Assessment

Next Health's flagship longevity assessment at $14,500, combining a 75-minute full-body MRI, chest CT, CT calcium score, InBody body composition scan, TrueAge epigenetic age test, Galleri multi-cancer blood test, 500+ biomarker blood panel, and a comprehensive hormone evaluation. Delivered over multiple appointments with a personalised one-year follow-up plan including quarterly blood baseline reviews.

The Executive Physical at Next Health San Francisco is the brand's most comprehensive longevity and preventive health programme, priced at $14,500 and delivered across multiple sessions. It is designed to provide the deepest available clinical picture of an individual's current health and longevity risk profile, going substantially beyond what an annual wellness physical or even a standard executive health check provides. The programme combines imaging, laboratory, epigenetic, and clinical assessment modalities in a coordinated protocol. Imaging: a 75-minute full-body MRI provides soft tissue visualisation of major organs, the spine, and lymph nodes without ionising radiation — enabling detection of incidental findings such as organ anomalies, vascular aneurysms, and early tumour signals. A chest CT provides high-resolution lung imaging for early lung nodule detection (highly relevant for current or former smokers). A CT calcium score quantifies coronary artery calcification, the most powerful predictor of future cardiovascular events available through non-invasive imaging. Diagnostics: the 500+ biomarker Total Baseline Blood Test (the brand's most comprehensive panel) is incorporated, alongside a hormone evaluation covering sex hormones, thyroid, adrenal, and metabolic markers. The Galleri multi-cancer early detection test is included, screening cell-free DNA methylation signals for 50+ cancer types from a single blood draw. Body composition: the InBody bioimpedance analysis scan provides lean mass, fat mass, visceral fat, and segmental distribution measurements as a baseline for monitoring the body composition improvements that lifestyle intervention and hormone optimisation may produce. Epigenetics: the TrueAge biological age test assesses DNA methylation patterns across key longevity-linked genomic sites to derive a biological age estimate — an indicator of how fast an individual is biologically ageing relative to chronological age. Follow-up: the programme includes a personalised one-year health optimisation plan with quarterly blood baseline tests and provider reviews, enabling longitudinal tracking of improvement from interventions undertaken after the assessment.